logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    La Thangue, Nicholas Barrie, Prof
    Born in November 1957
    Individual (8 offsprings)
    Officer
    icon of calendar 2004-06-24 ~ now
    OF - Director → CIF 0
  • 2
    CELLERON THERAPEUTICS HOLDINGS LIMITED - 2023-01-26
    icon of addressMagdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, United Kingdom
    Active Corporate (6 parents, 2 offsprings)
    Equity (Company account)
    -5,206,795 GBP2024-12-31
    Person with significant control
    icon of calendar 2022-12-22 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 13
  • 1
    Taylor, Richard Kirby
    Finance Professional born in October 1959
    Individual
    Officer
    icon of calendar 2021-09-13 ~ 2023-02-21
    OF - Director → CIF 0
  • 2
    Williams, Robert John, Dr
    Academic born in November 1961
    Individual
    Officer
    icon of calendar 2004-06-24 ~ 2005-03-09
    OF - Director → CIF 0
  • 3
    Chun, Ji Woong
    Bio Tech Investor & Pharmacist born in March 1982
    Individual
    Officer
    icon of calendar 2016-12-16 ~ 2021-11-23
    OF - Director → CIF 0
  • 4
    Kerr, David James, Professor
    Scientist born in June 1956
    Individual (6 offsprings)
    Officer
    icon of calendar 2005-03-09 ~ 2011-02-18
    OF - Director → CIF 0
    Kerr, David James, Prof
    Director born in June 1956
    Individual (6 offsprings)
    Officer
    icon of calendar 2011-09-30 ~ 2023-02-21
    OF - Director → CIF 0
  • 5
    Mcdonald, Douglas Fraser
    Individual (19 offsprings)
    Officer
    icon of calendar 2009-04-17 ~ 2022-12-22
    OF - Secretary → CIF 0
  • 6
    Lee, Sangwoo
    Executive Director born in June 1971
    Individual
    Officer
    icon of calendar 2016-09-23 ~ 2022-12-22
    OF - Director → CIF 0
  • 7
    Manion, Doug
    Ceo Kleo Pharmaceuticals born in June 1960
    Individual
    Officer
    icon of calendar 2017-05-17 ~ 2021-08-31
    OF - Director → CIF 0
  • 8
    Noble, James Julian
    Director born in March 1959
    Individual (1 offspring)
    Officer
    icon of calendar 2019-10-22 ~ 2023-02-21
    OF - Director → CIF 0
  • 9
    Whittaker, Frederick John, Dr
    Clinical Research born in October 1955
    Individual (2 offsprings)
    Officer
    icon of calendar 2012-10-01 ~ 2017-05-17
    OF - Director → CIF 0
  • 10
    Fleming, William John Robert
    Chief Financial Officer born in October 1966
    Individual (2 offsprings)
    Officer
    icon of calendar 2021-08-16 ~ 2024-09-18
    OF - Director → CIF 0
  • 11
    Innes-ker, Katherine, Dr
    Chair And Non Executive Director born in May 1960
    Individual
    Officer
    icon of calendar 2021-09-13 ~ 2022-03-24
    OF - Director → CIF 0
  • 12
    Prof Nicholas Barrie La Thangue
    Born in November 1957
    Individual (8 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2022-12-22
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 13
    HALE AND DORR SECRETARIES LIMITED - 2004-07-05
    BHD SECRETARIES LIMITED - 2003-03-07
    icon of address5th Floor Alder Castle, 10 Noble Street, London
    Dissolved Corporate (1 parent, 16 offsprings)
    Equity (Company account)
    1 GBP2020-09-30
    Officer
    2004-06-24 ~ 2009-04-17
    PE - Secretary → CIF 0
parent relation
Company in focus

CELLERON THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
0 GBP2024-12-31
198,486 GBP2023-06-30
Property, Plant & Equipment
0 GBP2024-12-31
531 GBP2023-06-30
Fixed Assets - Investments
100 GBP2024-12-31
100 GBP2023-06-30
Fixed Assets
100 GBP2024-12-31
199,117 GBP2023-06-30
Debtors
264,269 GBP2024-12-31
150,292 GBP2023-06-30
Cash at bank and in hand
225,487 GBP2024-12-31
83,554 GBP2023-06-30
Current Assets
489,756 GBP2024-12-31
233,846 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-25,819 GBP2024-12-31
Net Current Assets/Liabilities
463,937 GBP2024-12-31
-1,022,271 GBP2023-06-30
Total Assets Less Current Liabilities
464,037 GBP2024-12-31
-823,154 GBP2023-06-30
Equity
Called up share capital
1,885 GBP2024-12-31
1,885 GBP2023-06-30
Share premium
0 GBP2024-12-31
12,051,519 GBP2023-06-30
Other miscellaneous reserve
0 GBP2024-12-31
883,401 GBP2023-06-30
Retained earnings (accumulated losses)
462,152 GBP2024-12-31
-13,759,959 GBP2023-06-30
Equity
464,037 GBP2024-12-31
-823,154 GBP2023-06-30
Average Number of Employees
72023-07-01 ~ 2024-12-31
82022-07-01 ~ 2023-06-30
Property, Plant & Equipment - Gross Cost
Computers
0 GBP2024-12-31
7,330 GBP2023-06-30
Property, Plant & Equipment - Other Disposals
Computers
-7,330 GBP2023-07-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
0 GBP2024-12-31
6,799 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
531 GBP2023-07-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Computers
-7,330 GBP2023-07-01 ~ 2024-12-31
Property, Plant & Equipment
Computers
0 GBP2024-12-31
531 GBP2023-06-30
Other Investments Other Than Loans
100 GBP2024-12-31
100 GBP2023-06-30
Amount of corporation tax that is recoverable
Current
0 GBP2024-12-31
143,459 GBP2023-06-30
Amounts Owed By Related Parties
259,171 GBP2024-12-31
Current
0 GBP2023-06-30
Other Debtors
Amounts falling due within one year
5,098 GBP2024-12-31
6,833 GBP2023-06-30
Debtors
Current, Amounts falling due within one year
264,269 GBP2024-12-31
Amounts falling due within one year, Current
150,292 GBP2023-06-30
Trade Creditors/Trade Payables
Current
0 GBP2024-12-31
48,514 GBP2023-06-30
Amounts owed to group undertakings
Current
0 GBP2024-12-31
597,996 GBP2023-06-30
Other Taxation & Social Security Payable
Current
25,819 GBP2024-12-31
72,469 GBP2023-06-30
Other Creditors
Current
0 GBP2024-12-31
537,138 GBP2023-06-30
Creditors
Current
25,819 GBP2024-12-31
1,256,117 GBP2023-06-30
Par Value of Share
Class 1 ordinary share
0 GBP2023-07-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,884,586 shares2024-12-31
1,884,586 shares2023-06-30

  • CELLERON THERAPEUTICS LIMITED
    Info
    Registered number 05162047
    icon of addressMagdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford OX4 4GA
    PRIVATE LIMITED COMPANY incorporated on 2004-06-24 (21 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2025-06-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.